LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

RUBICON

NSEBSE
Rubicon Research Limited
Healthcare· Pharmaceuticals & Biotechnology· INE506V01022· Scrip: 544578
ENहिन्दीગુજરાતીमराठी
953.65
14.95 (+1.59%)
27/4/2026, 11:03:56 am
NSE
953.65
14.95
+1.59%
BSE
938.65
10.90
+0.00%
57466775985194310-1611-1712-1501-1302-1203-1304-2104-24
124 trading days · 1Y period
TODAY
Open951.30
High970.00
Low940.00
Prev Close938.70
Volume1.25L
Value₹11.9Cr
L: 940.00H: 970.00
52 WEEK
Low570.75
High970.00
96% of 52W range
Info
Face Value₹1
Listed2025-10-16
ISININE506V01022
SeriesB
BSE Scrip544578

Key Metrics

1D
+2.82%
1W
+6.09%
1M
+26.78%
3M
+40.84%
6M
Valuation
Mkt Cap₹12768 Cr
Growth (QoQ)
Revenue+15.41%
PAT+35.18%
EPS+27.79%

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr119 Cr238 Cr357 Cr476 Cr25-0925-123.54.5
QuarterRevenueExpensesEBITDAPBTPATEPS
2025-12-31476 Cr389 Cr102 Cr91 Cr73 Cr4.46
2025-09-30412 Cr341 Cr84 Cr72 Cr54 Cr3.49

Shareholding Pattern

CURRENT2026-03-31
59.9%PROMOTER
Promoter59.9%
FII7.5%
DII10.0%
Public40.1%
PROMOTER HOLDING TREND
60.0%25-1060.0%25-1259.9%26-03

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-04-24929.95944.95919.25938.702.13L
2026-04-23939.35948.00916.90927.502.53L
2026-04-22927.80944.30922.15933.951.75L
2026-04-21940.00952.70915.95921.354.49L
2026-04-20907.15938.70891.05927.553.67L
2026-04-17888.00913.10873.00898.904.49L
2026-04-16861.00904.20828.15870.6012.90L
2026-04-15830.10839.35815.85821.301.93L
2026-04-13830.00830.70815.00819.752.05L
2026-04-10868.30885.80830.25836.105.77L
2026-04-09798.00864.00795.70856.206.98L
2026-04-08812.55816.00787.05798.501.80L
2026-04-07774.00789.45769.45778.701.90L
2026-04-02777.00780.00765.20774.8571,487
2026-04-01775.55797.00773.00782.104.38L
2026-03-27773.60789.00758.50767.852.61L
2026-03-25795.60814.50768.50773.604.16L
2026-03-24789.90795.60769.60790.6095,323
2026-03-20760.60788.60758.30782.9584,344
2026-03-19751.60772.50747.75757.4582,510
2026-03-18752.00775.35752.00767.9096,064
2026-03-17750.00767.85746.00752.2093,639
2026-03-16767.70784.20744.00747.601.66L
2026-03-13799.00799.00759.50768.801.69L
2026-03-12778.00820.40768.95799.151.74L
2026-03-11795.00797.90775.60781.5558,499
2026-03-10776.80797.50772.25788.901.53L
2026-03-09751.00781.00732.30770.501.30L
2026-03-06758.00776.05755.15765.8566,949
2026-03-05761.00769.40732.05751.553.02L

Frequently Asked Questions

About

Rubicon Research Limited is an Indian pharmaceutical formulations company focused on research and development, specializing in specialty products and drug-device combination products targeting regulated markets, particularly the United States. The company operates internationally, with a significant portfolio including over 55 commercialized products in the US as of March 31, 2024, and has expanded its offerings to include various dosage forms such as oral capsules, concentrates, and ophthalmic drops. Rubicon Research Limited is listed on the National Stock Exchange of India (NSE) under the symbol RUBICON.

BOARD OF DIRECTORS